Exon 1 Disruption Alters Tissue-Specific Expression of Mouse p53 and Results in Selective Development of B Cell Lymphomas

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chiang, Y Jeffrey ^a   Difilippantonio, Michael J ^a   Tessarollo, Lino ^b   Morse, Herbert C ^c   Hodes, Richard J ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CRE RECOMBINASE; MESSENGER RNA; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CARCINOGENESIS; CONTROLLED STUDY; EXON; KNOCKOUT GENE; LYMPHOCYTE SUBPOPULATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SPLENIC MARGINAL ZONE LYMPHOMA; THYMOCYTE; THYMUS; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DNA PRIMERS; EXONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; KARYOTYPING; LYMPHOMA, B-CELL; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84869131242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049305     Document Type: Article

References (34)

1. Belyi VA, Ak P, Markert E, Wang H, Hu W, et al. (2010) The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2: a001198.
2. Feng Z, Hu W, Rajagopal G, Levine AJ, (2008) The tumor suppressor p53: cancer and aging. Cell Cycle 7: 842-847.
3. Hussain SP, Harris CC, (2006) p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis. J Nippon Med Sch 73: 54-64.
4. Sengupta S, Harris CC, (2005) p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6: 44-55.
5. Robles AI, Harris CC, (2010) Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol 2: a001016.
6. Attardi LD, Jacks T, (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 55: 48-63.
7. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, et al. (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9: 882-895.
8. Kenzelmann Broz D, Attardi LD, (2010) In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models. Carcinogenesis 31: 1311-1318.
9. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
10. Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA, (1993) Genetic background alters the spectrum of tumors that develop in p53-deficient mice. Faseb J 7: 938-943.
11. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7.
12. Rickert RC, Roes J, Rajewsky K, (1997) B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25: 1317-1318.
13. Southon E, Tessarollo L, (2009) Manipulating mouse embryonic stem cells. Methods Mol Biol 530: 165-185.
14. Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, et al. (2008) Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS ONE 3: e2639.
15. Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, et al. (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220.
16. Chiang J, Hodes RJ, (2011) Cbl enforces Vav1 dependence and a restricted pathway of T cell development. PLoS One 6: e18542.
17. Ogawa Y, Nishioka A, Inomata T, Kataoka S, Nakayama K, et al. (2000) Ionizing radiation-induced apoptosis in human lymphoma cell lines differing in p53 status. Int J Mol Med 5: 139-143.
18. Morse HC 3rd, Anver MR, Fredrickson TN, Haines DC, Harris AW, et al. (2002) Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100: 246-258.
19. Padilla-Nash HM, Barenboim-Stapleton L, Difilippantonio MJ, Ried T, (2006) Spectral karyotyping analysis of human and mouse chromosomes. Nat Protoc 1: 3129-3142.
20. Lavin MF, Gueven N, (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13: 941-950.
21. Mothersill C, Seymour CB, Harney J, Hennessy TP, (1994) High levels of stable p53 protein and the expression of c-myc in cultured human epithelial tissue after cobalt-60 irradiation. Radiat Res 137: 317-322.
22. Ward JM, Tadesse-Heath L, Perkins SN, Chattopadhyay SK, Hursting SD, et al. (1999) Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice. Lab Invest 79: 3-14.
23. Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D, (2001) p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 97: 3552-3558.
24. Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, et al. (2010) Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J Pathol 220: 461-474.
25. Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, et al. (2010) Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 116: 1479-1488.
26. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, et al. (2002) Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99: 6955-6960.
27. Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, et al. (2010) Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med 207: 2407-2420.
28. Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, et al. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109: 5079-5086.
29. Bassing CH, Tillman RE, Woodman BB, Canty D, Monroe RJ, et al. (2003) T cell receptor (TCR) alpha/delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes. Proc Natl Acad Sci U S A 100: 2598-2603.
30. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, et al. (2003) H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114: 371-383.
31. Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, et al. (2002) Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 196: 469-480.
32. Gladdy RA, Taylor MD, Williams CJ, Grandal I, Karaskova J, et al. (2003) The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 3: 37-50.
33. Rowh MA, DeMicco A, Horowitz JE, Yin B, Yang-Iott KS, et al. (2011) Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations. Oncogene 30: 4757-4764.
34. Rui L, Goodnow CC, (2006) Lymphoma and the control of B cell growth and differentiation. Curr Mol Med 6: 291-308.